Global Bio Pharma Logistics Market 2015-2019 - Increase in Outsourcing of Bio Pharmaceutical Labeling and Packaging

News provided by

Oct 28, 2015, 03:10 ET

DUBLIN, Oct. 28, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/fkx4j4/global_bio_pharma) has announced the addition of the "Global Bio Pharma Logistics Market 2015-2019" report to their offering.

The global bio pharma logistics market to grow at a CAGR of 3.91 % over the period 2014-2019.

The report, Global Bio Pharma Logistics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, North America, and ROW. It also covers the landscape of the global bio pharma logistics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

This report covers the present scenario and the growth prospects of the global bio pharma logistics market for 2015-2019. To calculate the market size, this report covers revenue generated by the vendors in the global bio pharma logistics market.

The market is witnessing certain trends that are expected to contribute to its growth during the forecast period. One of these trends is the increase in outsourcing of bio pharma labeling and packaging activities to 3PL and 4PL companies. This helps the manufacturing companies to focus on core activities like the procurement of raw materials and distribution of the products.

According to the report, many drivers contribute to the growth of the global bio pharma logistics market. One such driver is the increased demand for temperature-sensitive pharmaceutical drugs like vaccines and blood products, which has led to a boost in the demand for cold chain logistics services for the delivery of these products.

Further, the report states that one of the challenges that restrict the growth of the global bio pharma logistics market is the presence of stringent regulations on the manufacturing quality of bio pharma drugs.

The market is segmented on the following: